Praca, EduardoJalou, HasnaaKrupp, NadiaDelecaris, AngelaHatch, JosephSlaven, JamesGunst, Susan J.Tepper, Robert S.2019-12-272019-12-272019-04Praca, E., Jalou, H., Krupp, N., Delecaris, A., Hatch, J., Slaven, J., … Tepper, R. S. (2019). Effect of CPAP on airway reactivity and airway inflammation in children with moderate-severe asthma. Respirology (Carlton, Vic.), 24(4), 338–344. doi:10.1111/resp.13441https://hdl.handle.net/1805/21596BACKGROUND AND OBJECTIVE: Asthma is characterized by airway hyperreactivity and airway inflammation. We previously demonstrated that adults with mild well-controlled asthma exhibited a marked decrease in airway reactivity (PC20 increased >2-fold) after using nocturnal continuous positive airway pressure (CPAP) for 1 week. If CPAP produces a similar suppression of airway reactivity in children with moderate-severe asthma, who require chronic use of corticosteroids, then this non-pharmacological therapy might provide a beneficial alternative or supplemental therapy in these subjects. METHODS: Children aged 8-17 years with moderate-severe asthma were treated with 4 weeks of nocturnal CPAP (8-10 cm H2 O) or sham CPAP (<2 cm H2 O). Adherence was monitored with a modem installed in the equipment or by memory cards. Airway reactivity, assessed by methacholine bronchial challenge, was measured prior to and following treatment. RESULTS: The percentage of subjects adherent to treatment was similar in both groups (19/27 CPAP vs 19/28 sham, ~70%). There was a tendency for PC20 to increase with treatment in both groups (3.0-5.3 mg/mL CPAP vs 3.2 to 4.3 mg/mL sham, P = 0.083); however, the change did not differ significantly between groups (P = 0.569). CONCLUSION: We found that the 4-week treatment with nocturnal CPAP did not produce a twofold suppression of airway reactivity in children with moderate-severe asthma.en-USPublisher PolicyBronchial challengeChronic mechanical strainInduced sputumLung functionArticle